About SeQuent
SeQuent is a company based in Bengaluru (India) founded in 2002 was acquired by The Carlyle Group in May 2020. The company has 1,430 employees as of March 31, 2024. SeQuent has completed 1 acquisition, including Indo Phyto Chemicals. SeQuent offers products and services including APIs, FDFs, and Analytical Services. SeQuent operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and Sterling Pharma Solutions, among others.
- Headquarter Bengaluru, India
- Employees 1430 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sequent Scientific Limited
-
Annual Revenue
$180.96 M (USD)13.23as on Mar 31, 2024
-
Net Profit
$2.56 M (USD)160.99as on Mar 31, 2024
-
EBITDA
$18.81 M (USD)147.59as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
The Carlyle Group
& 3 more
-
Employee Count
1430
as on Mar 31, 2024
- Investments & Acquisitions
-
Acquired by
The Carlyle Group
(May 08, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SeQuent
SeQuent is a publicly listed company on the NSE with ticker symbol SEQUENT in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of SeQuent
SeQuent offers a comprehensive portfolio of products and services, including APIs, FDFs, and Analytical Services.
Active ingredients for veterinary medications
Finished dosage forms for animal health care
Testing and analysis for animal health products
People of SeQuent
Unlock access to complete
Funding Insights of SeQuent
Investors in SeQuent
SeQuent has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include The Carlyle Group, Ascent Capital and Convergent Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AscentCapital is engaged in potato farming, grain marketing, and equipment services in Maine.
|
Locked | Locked | Locked | |
|
Private equity investments are directed toward multiple sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for SeQuent
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SeQuent
SeQuent has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Indo Phyto Chemicals.
Investment portfolio details for SeQuent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer & supplier of active pharmaceutical ingredients
|
Locked | Locked | 1978 | Locked |
Complete acquisition details for SeQuent
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SeQuent
Detailed financials for SeQuent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sequent Comparisons
Peer comparison for SeQuent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SeQuent
SeQuent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and Sterling Pharma Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of SeQuent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sequent
Complete news archive for SeQuent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SeQuent
SeQuent was founded in 2002 and raised its 1st funding round 12 years after it was founded.
SeQuent is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
As of Mar 31, 2024, the latest employee count at SeQuent is 1,430.
Annual revenue of SeQuent is $180.96M as on Mar 31, 2024.
SeQuent was established in 2002 in Bengaluru, India, focusing on the pharmaceutical sector. Active pharmaceutical ingredients (APIs) are produced for various therapeutic areas through three manufacturing facilities located in Karnataka and Maharashtra. Contract research services are provided by its research arm, SeQuent Research Limited, specializing in analytical and bioanalytical support for API, pharmaceutical, personal care, and nutraceutical companies.
SeQuent's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
SeQuent offers APIs, FDFs, and Analytical Services.
Yes, SeQuent is publicly traded on NSE under the ticker symbol SEQUENT.
SeQuent has made 1 acquisition, including Indo Phyto Chemicals.
SeQuent has 3 investors. Key investors include The Carlyle Group, Ascent Capital, and Convergent Finance.
The ticker symbol of SeQuent is SEQUENT on NSE.